Clinical Trials in Dallas

Showing 7681-7700 of 17,468 trials

PARP Inhibition During Pre-surgical Window in Breast/Ovary Cancer

NCT04041128

Study involves surgery for cytoreduction or laparoscopy to determine if you are a candidate for tumor debulking or a tissue biopsy. Following this surgery you will receive chemotherapy. This study will administer 7 days of treatment with a targeted therapy called Lynparza. Lynparza and/or other PARP inhibitors have been FDA approved for the treatment of ovarian and breast cancer. Tissue biopsy will be done before a 7 day course of Lynparza in order to correlate molecular changes to response to treatment. Participation in this trial will require an additional tumor biopsy which will occur either before or after treatment of Lynparza.

Ovarian CancerBreast Cancer

University of Texas Southwestern Medical Center14 participantsStarted Jul 2019

Dallas, Texas, United States

COMPLETEDPhase 2< 1 mile

A Study to Evaluate the Dose Response Based on the Efficacy, Safety and Tolerability of Bimekizumab in Subjects With Active Psoriatic Arthritis Which is a Type of Inflammatory Arthritis

NCT02969525

This is a study to evaluate the dose response based on the efficacy, safety and tolerability of bimekizumab in subjects with active psoriatic arthritis.

Psoriatic Arthritis

UCB Biopharma S.P.R.L.206 participantsStarted Oct 2016

San Diego, California, United States • Aventura, Florida, United States • Hagerstown, Maryland, United States +37 more locations

PARP Inhibition During Pre-surgical Window in Breast/Ovary Cancer

A Study to Evaluate the Dose Response Based on the Efficacy, Safety and Tolerability of Bimekizumab in Subjects With Active Psoriatic Arthritis Which is a Type of Inflammatory Arthritis

Find Trials by Condition in Dallas

Assessment of INS1007 in Participants With Non-Cystic Fibrosis Bronchiectasis

Genetic Data Collection in Adult Participants to Identify Genetic Variants of Known Importance in Non-alcoholic Steatohepatitis (NASH)

CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma

Study to Assess How ABBV-951 is Absorbed When Administered at Different Subcutaneous Sites of Adult Participants With Parkinson's Disease

OPTIMIZE IDE for the Treatment of ACS

Efficacy Evaluation of Sabizabulin Monotherapy Versus Active Control for Treatment of ER+HER2- Metastatic Breast Cancer

A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its Safety

A Study of EDP1503 in Patients With Colorectal Cancer, Breast Cancer, and Checkpoint Inhibitor Relapsed Tumors

Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance

Tomivosertib (eFT-508) in Combination With PD-1/PD-L1 Inhibitor Therapy

A Phase 2 Study of Axalimogene Filolisbac (ADXS11-001) in Participants With Carcinoma of the Anorectal Canal

(EXPLORER) Study of BLU-285 in Patients With Advanced Systemic Mastocytosis (AdvSM) and Relapsed or Refractory Myeloid Malignancies

Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19

An Extension Trial of Inclisiran in Participants With Cardiovascular Disease and High Cholesterol

FREEDOM COVID-19 Anticoagulation Strategy

A Study of Tirzepatide (LY3298176) in Participants With Impaired Kidney Function

Immunogenicity of Novel H1N1 Vaccination Among HIV-Infected Compared to HIV-Uninfected Persons

The TREFOIL Concept 5 Year Clinical Investigation